Assessing suboxone access in community pharmacies: Secret shopper model
- PMID: 38023634
- PMCID: PMC10663689
- DOI: 10.1016/j.rcsop.2023.100356
Assessing suboxone access in community pharmacies: Secret shopper model
Abstract
Objective: To assess whether Maryland community pharmacies had Suboxone available for dispensing.
Methods: This cross-sectional study used a secret shopper model to contact public-facing community pharmacies in Maryland. The secret shopper, guided by a script, asked whether a prescription for Suboxone was available for the same or next day pick-up. A small convenience sample of pharmacies who did not have Suboxone available received an in-person visit to inquire about medication availability and dispensing barriers.
Results: After contacting 99% (n = 1046) of Maryland public-facing pharmacies, Suboxone was confirmed available for immediate pick-up in 31% (n = 326). The remaining did not have, would not disclose, or had limited access (existing patients or specific providers only). Significant differences in Suboxone availability were found for National Capital vs. Baltimore metro region and when pharmacist asked questions vs. no questions. Of the 11 pharmacy visits completed, 10 said they had Suboxone currently in stock, with one clarifying medication was for existing patients only.
Conclusion: About 69% of patients may face challenges when calling to find out whether they can obtain Suboxone in Maryland pharmacies. Better patient education and more thorough pharmacy-level investigation of system and workflow barriers could offer solutions.
Keywords: Buprenorphine/naloxone; Pharmacies; Pharmacists; Pharmacy; Suboxone.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Rural community pharmacist willingness to dispense Suboxone® - A secret shopper investigation in South-Central Appalachia.Explor Res Clin Soc Pharm. 2021 Oct 23;4:100082. doi: 10.1016/j.rcsop.2021.100082. eCollection 2021 Dec. Explor Res Clin Soc Pharm. 2021. PMID: 35479845 Free PMC article.
-
Pharmacist counseling when dispensing naloxone by standing order: A secret shopper study of 4 chain pharmacies.J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e94-e99. doi: 10.1016/j.japh.2020.10.010. Epub 2020 Nov 3. J Am Pharm Assoc (2003). 2021. PMID: 33153912
-
Naloxone availability in independent community pharmacies in Georgia, 2019.Subst Abuse Treat Prev Policy. 2021 Aug 21;16(1):63. doi: 10.1186/s13011-021-00402-w. Subst Abuse Treat Prev Policy. 2021. PMID: 34419089 Free PMC article.
-
Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.J Subst Abuse Treat. 2021 Oct;129:108372. doi: 10.1016/j.jsat.2021.108372. Epub 2021 Mar 27. J Subst Abuse Treat. 2021. PMID: 34080543 Free PMC article. Review.
-
Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review.J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1725-1740. doi: 10.1016/j.japh.2022.07.008. Epub 2022 Jul 31. J Am Pharm Assoc (2003). 2022. PMID: 35989151 Review.
Cited by
-
Come back when you're infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023.Harm Reduct J. 2024 Feb 22;21(1):49. doi: 10.1186/s12954-024-00943-w. Harm Reduct J. 2024. PMID: 38388463 Free PMC article.
References
-
- The A.S.A.M. National Practice Guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med. 2020;14(2S):1–91. - PubMed
LinkOut - more resources
Full Text Sources